Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DR26FAEVT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,934
Award facts
- Contract value 100% obligated
- $24,934.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $24,934 delivery order to Amerisourcebergen Drug Corp on July 14, 2026, for SKYRIZI 360 MG/2.4 ML on-body injectable pharmaceutical product, with an ultimate completion date of August 4, 2026.
Place of performance is Conshohocken, PA. This is a firm fixed-price delivery order against the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract, which supports worldwide military healthcare supply. No set-aside applied to this order.
Quick answers
Who was awarded contract SPE2DR26FAEVT?
SPE2DR26FAEVT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26FAEVT worth?
The government has obligated $24,934 on SPE2DR26FAEVT.
Is contract SPE2DR26FAEVT an order under another contract?
Yes. SPE2DR26FAEVT is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FAEVT competed?
The extent of competition for SPE2DR26FAEVT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award